Investigators at University of Oxford Detail Findings in Malaria (Efficacy and Immunogenicity of R21/matrix-m Vaccine Against Clinical Malaria After 2 Years' Follow-up In Children In Burkina Faso: a Phase 1/2b Randomised Controlled Trial).

Předmět:	VACCINE immunogenicity MALARIA BOOSTER vaccines VACCINE effectiveness PROTOZOAN diseases
Zdroj:	Zika & Mosquito Week; 2/3/2023, p541-541, 1p
Abstrakt:	In the high-dose adjuvant group, vaccine efficacy against multiple episodes of malaria was 78% (95% CI 71 to 83), and 2285 (95% CI 1911 to 2568) cases of malaria were averted per 1000 child-years at risk among vaccinated children in the second year of follow-up. Keywords: Oxford; United Kingdom; Europe; Biological Products; Clinical Research; Clinical Trials and Studies; Health and Medicine; Immunization; Immunization and Public Health; Malaria; Mosquito-Borne Diseases; Pediatric Vaccines; Pediatrics; Protozoan Infections; Public Health; Rabies Vaccines; Vaccination; Vaccine Efficacy; Vaccines; Viral Vaccines; University of Oxford EN Oxford United Kingdom Europe Biological Products Clinical Research Clinical Trials and Studies Health and Medicine Immunization Immunization and Public Health Malaria Mosquito-Borne Diseases Pediatric Vaccines Pediatrics Protozoan Infections Public Health Rabies Vaccines Vaccination Vaccine Efficacy Vaccines Viral Vaccines University of Oxford Current study results on Mosquito-Borne Diseases - Malaria have been published. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu